全胸骨切开与微创胸骨部分切开主动脉瓣置换术后的生活质量比较
该研究基于欧洲多中心前瞻性注册数据库,纳入1844例连续接受主动脉瓣置换术的患者,按手术入路分为全胸骨切开组(1654例)和微创胸骨部分切开组(190例)。经倾向性评分匹配后各187对患者,比较两组院内结局及术后1年内的生活质量(SF-36量表PCS和MCS评分)。结果显示匹配后两组基线特征和院内结局相当,生活质量的改善随时间变化组间无差异,微创入路在生活质量方面似乎未显示出优势。
要点
- 匹配后全胸骨切开与微创胸骨部分切开主动脉瓣置换术的院内结局相当(所有终点P=无显著差异)。
- 术后1年内两组身体和心理健康改善程度相当,组间-时间交互作用无显著差异(PCS P=0.834,MCS P=0.737)。
- 就生活质量而言,微创胸骨部分切开相比传统全胸骨切开似乎未提供任何优势。
核心结论
- 在基线特征相似的患者中,全胸骨切开与微创胸骨部分切开主动脉瓣置换术的院内结局相当,术后1年内身体和心理健康改善程度也相当;就生活质量而言,微创胸骨部分切开似乎未提供任何优势。
研究设计与样本
- 研究为欧洲多中心前瞻性注册队列,共纳入1844例连续接受主动脉瓣置换术的患者,按手术入路分为全胸骨切开组(1654例)和微创胸骨部分切开组(190例)。
- 采用非节俭倾向性评分匹配选出187对基线特征可比的接受全胸骨切开或微创胸骨部分切开主动脉瓣置换术的患者。
- 生活质量采用SF-36量表评估,并细分为身体成分总结(PCS)评分和精神成分总结(MCS)评分,于入院时、出院时及术后1个月、6个月、1年进行测评。
主要发现
- 全胸骨切开组术前风险 profile 更差,重症监护室停留时间更长(59.7小时 vs 38.8小时;p=0.002),危及生命或致残性出血发生率更高(4.1% vs 0%;P=0.011);微创胸骨部分切开组因指数干预失败而早期再干预率更高(2.1% vs 0.5%;P=0.001)。
- 生活质量调查显示全胸骨切开组术后1个月时PCS和MCS更优,但时间趋势无差异(PCS组-时间P=0.202;MCS组-时间P=0.141)。
- 倾向性匹配对显示两组基线特征和院内结局相当(所有终点P=无显著差异),PCS和MCS随时间改善程度相当,但组间随时间无差异(PCS组-时间P=0.834;MCS组-时间P=0.737)。
临床怎么用
- 作者认为,就生活质量而言,微创胸骨部分切开相比传统全胸骨切开似乎未提供任何优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few longitudinal data exist comparing quality of life (QoL) after full sternotomy (fs) aortic valve replacement (AVR) (fsAVR) with ministernotomy AVR (msAVR). METHODS: A total of 1844 consecutive patients undergoing AVR who were prospectively enrolled in a European multicenter registry were dichotomized according to surgical access. Nonparsimonious propensity score matching selected 187 pairs of patients who underwent fsAVR or msAVR with comparable baseline characteristics. Hospital outcome was compared in the 2 groups. QoL was assessed with the Short Form-36, further detailed in its Physical Component Summary (PCS) score and the Mental Component Summary (MCS) score. QoL was investigated at hospital admission, at discharge, and at 1 month, 6 months, and 1 year thereafter. RESULTS: There were 1654 patients undergoing fsAVR and 190 undergoing msAVR in the entire population. The fsAVR group showed a worse preoperative risk profile, a longer intensive care unit length of stay (59.7 hours vs 38.8 hours; p = .002), and a higher rate of life-threatening or disabling bleeding (4.1% vs 0%; P = .011); the msAVR group had a higher rate of early reintervention for failed index intervention (2.1% vs 0.5%; P = .001). QoL investigations showed better PCS and MCS at 1 month after fsAVR, but no temporal trend differences (PCS group-time P = .202; MCS group-time P = .141). Propensity-matched pairs showed comparable baseline characteristics and hospital outcomes (P = not significant for all end points) and comparable improvements of PCS and MCS over time, but no between-group differences over time (PCS group time P = .834; MCS group time P = .737). CONCLUSIONS: Patients with similar baseline profiles report comparable hospital outcomes and comparable improvements of physical and mental health, up to 1 year after surgery, with both fsAVR and msAVR. As for QoL, ministernotomy does not seem to offer any advantage compared with the traditional approach.
引用
- Perrotti A, Francica A, Monaco F, et al. Postoperative Quality of Life After Full-sternotomy and Ministernotomy Aortic Valve Replacement. Ann Thorac Surg. 2021. PMID: 34971595. doi:10.1016/j.athoracsur.2021.11.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。